Purpose: The magnetic field can cause a nonnegligible dosimetric effect in an MRLinac system. This effect should be accurately accounted for by the beam models in treatment planning systems (TPS). The purpose of the study was to verify the beam model and the entire treatment planning and delivery process for a 1.5 T MR-Linac based on comprehensive dosimetric measurements and end-to-end tests. Results: For the depth dose measurements with Farmer IC, micro IC and diamond detector, the absolute difference between most measurement points and beam model calculation beyond the buildup region were <1%, at most 2% for a few measurement points. For the beam profile measurements, the absolute differences were no more than 1% outside the penumbra region and no more than 2.5% inside the penumbra region. Results of end-to-end tests demonstrated that three 3D static plans with single 5 × 10 cm 2 fields (at gantry angle 0°, 90°and 270°) and two IMRT plans successfully passed gamma analysis with clinical criteria. The dose difference in the inhomogeneous phantom between the calculation and measurement was within 1.0%. 
| INTRODUCTION
Integrated MRI guided radiation therapy (MRgRT) systems are emerging radiation therapy (RT) techniques that combine a MR-scanner with either a linear accelerator (MR-Linac) [1] [2] [3] or Co-60 teletherapy system. 4 The main magnetic field of the MRI is oriented either longitudinal or transverse to the central axis of the radiation beam.
Owing to MRI's capability to provide excellent soft-tissue contrast images and biological/functional information, these systems are expected to enable adaptive RT and provide real-time, high quality image guidance during delivery with the potential to significantly improve RT outcomes. However, the presence of the magnetic field (ranging from 0.35 to 1.5 T) has nonnegligible dosimetric effects in patients due to the Lorenz deflection effect of the secondary electrons from the primary photon beam. The responses of the radiation dose measurement devices are also affected by the presence of the magnetic field.
The dosimetric effect of a transverse magnetic field (TMF) in phantom and patients has been studied extensively. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Compared to conventional external beam RT without magnetic field, the magnetic field can generally lead to an altered buildup depth, and a larger, slightly shifted (asymmetric) penumbra arising from tilting of the dose kernel. 5 The dose deposited at tissue-air interfaces can increase due to the electron returning effect (ERE), 6 which can also be affected by the surface orientation where the photon beam enters or exits. 8 The dosimetric response of QA devices [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] (especially the detectors used for beam calibration) in magnetic fields have also been studied, focusing mainly on the absolute dose response of the detectors. The effect of the magnetic field on the detectors is demonstrated 26 not only through the trajectory path deflection of the secondary electrons in the medium surrounding and inside the volume of the gas-filled or solid detector, but also through the change of the intrinsic properties of detectors such as charge carrier versus lattice defect recombination, polarity effect, etc. For the ionization chamber, however, when the field size is sufficiently larger than the detector's diameter, an additional magnetic field and beam quality correction factor 18 can be applied to the original calibration coefficient, obtained without the magnetic field, to obtain the correct absolute dose calibration in the presence of the magnetic field.
The effective point of measurement (EPOM) of the ionization chamber 27 is shifted not only in the beam direction but also laterally, perpendicular to both the beam and the magnetic field direction.
According to O'Brien et al. 27 , the measured lateral shift in the dose distribution was independent of depth and field size from 2 × 2 cm 28 and considers a uniform magnetic field with strength and orientation as input. 29 The main purposes of this study were to: (a) validate the beam models in the TPS by comparing the model predictions with comprehensive dosimetric measurement data from the MR-Linac and (b) verify the performance of the entire planning and delivery process by carrying out a series of end-to-end tests on the MR-Linac.
| MATERIALS AND METHODS
All the measurement data were collected on a preclinical MR-Linac The dosimetric data in the same conditions of the measurements were generated with the prototype Monaco TPS using the beam model provided by the vendor. For the end-to-end tests, a variety of dosimetric plans including three 3D static plans with single rectangular fields and two IMRT patient and QA plans were generated using the TPS and were delivered on the MR-Linac. The details of the plans are described in Sections 2.52.1 and 2.62.2.
2.A | Water tank measurements
Most relative and absolute dosimetry measurements were performed using an in-house built water tank with a hand-cranked gear mecha- and the couch top when the detector located at the isocenter.
All measurements were performed with the gantry at 0°(i.e., perpendicular to the water surface). The field sizes and depth for all the PDD and beam profile measurements are listed in Tables 1 and 2 .
The field size is defined at the isocenter.
2.B | Radiochromic film measurements
Radiochromic film (GAFchromic EBT-3) was used as a secondary vali- 
The k Qmsr B
was chosen with reference to 
2.E | Data calculated from beam models
The dosimetric data in the same conditions as in the measurements described above were generated using the prototype Monaco TPS with the existing MR-Linac beam model (7.0FFF + cryostat) using a calculation grid of 3 mm × 3 mm × 3 mm. The data were extracted from 3D plans of single beams irradiating onto a rectangular water phantom similar to the water tank. The PDDs along the CAX and the beam profiles for each field size at corresponding depths were extracted from the corresponding 3D dose distributions.
2.F | End-to-end tests with an MR compatible 3D diode array
For the end-to-end tests, three single-beam 3D plans based on CT data of an MR-compatible cylindrical 3D diode array (ArcCheck, Field size/depth (cm) Model 1220-MR, Sun Nuclear Corporation, Melbourne, FL) were generated for a rectangular field of 5 × 10 cm 2 at gantry angles 0°, 90°, and 270°, respectively. In addition, two realistic step-and-shoot IMRT plans were generated based on two sample patient CT sets of pancreas cancer using commonly used dose-volume constraints 
2.G | Dose verification in inhomogeneous phantom
To verify the TPS dose calculation accuracy in inhomogeneous tissue, we performed dose measurements in a homemade phantom using an MR-compatible ion chamber (A26MR, Standard Imaging) with a sensitive volume of 0.016 cm Table 3 .
3.B | Cross-plane and in-plane beam profiles
Since the magnetic field affects dosimetry mostly in transverse planes, the majority of the data were collected in the cross-plane Table 4 ). As expected, no lateral shifts in in-plane beam profiles were observed and the dose distribution is symmetric and peaks at CAX for both measured and calculated data.
3.C | Reference dose verification
Based on the type of ion chamber and its orientation with respect to the irradiation and magnetic fields, a k Qmsr B of 0.994 was used for the reference dose verification. 18 The absolute dose at the measure- 
3.D | End-to-end tests
The three single-beam plans with a 5 × 10 cm 2 field at gantry 0°, 90°, and 270°were delivered to the ArcCheck and the measured dose was compared with the TPS calculations. distributions for one of the IMRT plan, along with the isodose lines of the patient and QA plans on patient and ArcCheck CTs. Both the relative and absolute dosimetric measurements on the MR-Linac indicate that the prototype Monaco TPS and beam model accurately account for the effects of the 1.5 T, transverse magnetic field. The end-to-end tests verified the entire treatment planning and delivery process.
3.E | Dose verification in inhomogeneous phantom

